Heifets LB et al. |
Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1532486
|
Guay DR and Craft JC |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. |
1992 |
J. Intern. Med. |
pmid:1532615
|
Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Derouin F et al. |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482160
|
Takeda H et al. |
[A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa]. |
1992 |
Kansenshogaku Zasshi |
pmid:1363435
|
Chapelsky MC et al. |
Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. |
1992 Jul-Aug |
Drug Saf |
pmid:1355971
|
Hoover WW et al. |
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. |
1992 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:1533827
|
de Campora E et al. |
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535578
|
Nilsen OG et al. |
Macrolide pharmacokinetics and dose scheduling of roxithromycin. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535579
|
Friend DR |
Polyacrylate resin microcapsules for taste masking of antibiotics. |
1992 Oct-Dec |
J Microencapsul |
pmid:1403495
|
Ruf B et al. |
Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. |
1992 Sep-Oct |
Infection |
pmid:1428183
|
Clark JA and Margolis DM |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex. |
1993 |
Clin. Infect. Dis. |
pmid:8513064
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Mor N and Heifets L |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328792
|
Klopman G et al. |
Anti-Mycobacterium avium activity of quinolones: in vitro activities. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239587
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|